Tumor infiltration with B cells is associated with a favorable response to immune checkpoint inhibitor (ICI) anti-PD(L)1 treatment that is designed to reinvigorate exhausted T cells (mostly CD8+ cytotoxic T cells) in tumor microenvironments. Here, CD274 is linked to neoplasm.